Amgen實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

Amgen 新聞

盧昕穎 2026 Mar 18, 00:00

霍爾木茲海峽控制權之爭:美伊衝突的終極戰役

張瑋庭 2026 Mar 18, 00:00

Meta新一輪裁員:冗餘削減還是AI投資回報?

張瑋庭 2026 Mar 18, 00:00

美情報官因不滿伊朗政策辭職,指控以色列施壓與虛假威脅

陳昊然 2026 Mar 18, 00:00

霍爾木茲海峽關閉加劇美國經濟前景惡化

林芷柔 2026 Mar 18, 00:00

地緣政治衝擊下的市場導航:伊朗衝突的投資者分析框架

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
陳昊然 2026 Mar 18, 00:00

地緣政治衝擊重塑聯準會抗通膨戰略,升息前景面臨嚴峻考驗

陳昊然 2026 Mar 18, 00:00

副總統范斯力挺川普伊朗政策,相信能避免重蹈覆轍

許景桓 2026 Mar 18, 00:00

比利時首相呼籲與俄羅斯能源關係正常化 歐盟內部引發激烈辯論

許景桓 2026 Mar 18, 00:00

美國各州納入黃金對沖經濟動盪,多元化資產配置趨勢顯現

陳昊然 2026 Mar 18, 00:00

地緣政治緊張局勢推升油價,外匯套利交易趁勢崛起

林芷柔 2026 Mar 18, 00:00

情報揭露:美曾警告攻伊恐引報復,特朗普稱事前毫無預警

張瑋庭 2026 Mar 18, 00:00

歐盟外長呼籲結束伊朗衝突,尋求荷莫茲海峽外交解決方案

盧昕穎 2026 Mar 18, 00:00

葉門胡塞武裝:伊朗在紅海戰略博弈中的關鍵棋子

聯絡方式

點差

2.24

點差(%)

0.6227 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期三

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

197433524224

流通股份

539067675

收益日期(下一個)

1999-11-22

現金殖利率 

2026-06-05

除息日

2026-05-15

遠期年股息率

10.08

遠期年現金殖利率

0.0275

每股盈餘

14.25

了解有關此金融工具的詳細資訊

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
林芷柔 2025 Oct 29, 16:00

進階交易策略:多頭部位 vs. 空頭部位,哪個更好?

黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

Trustpilot